Pharma Focus Asia
KP - Choose our fully recyclable blister films

Pfizer Launches First-of-its Kind Innovative Technologies for Hemophilia Patients

Pfizer announced the launch of Hemocraft™ a modification of the popular video game Minecraft®, and the HemMobile® Striiv® Wearable, a custom wristband. It helps people who suffer with hemophilia with better approaches and activity tracking in the US.

Hemocraft helps younger individuals with hemophilia, 8-16 years of age, to learn the importance of integrating treatment into their routine in an educational and fun gaming environment.

In addition, in Hemocraft, players go on a search and interact with the village doctor, a fictional health care professional character to learn how to stick to their treatment plan, stay prepared, and understand how treatment works.
Players are challenged to monitor factor levels and self-infuse to help control bleeding, if required, throughout the game. The downloadable modification is available via

These educational tools help people with a bleeding disorder to better understand the concept of factor levels in being able to stay active, and stay in the game.

Hemophilia is a rare bleeding disorder in which the body is unable to properly create a blood clot, affecting 20,000 people in the US and an estimated 400,000 people worldwide.

To help empower people with hemophilia to learn about and track different aspects relevant to their disease, these new digital innovations can be integrated into everyday routines.

Pfizer continually impact patients’ lives and pioneer a new era in hemophilia today, and in the future, through ongoing innovation, coupled with research and support programs.

Pfizer’s has introduced HemMobile Striiv Wearabl, the first wearable made for patients with hemophilia, offers an easy-to-use, comprehensive tool to track activity.

The device can be worn on the wrist and it contains several features including tracking daily activity levels and monitoring heart rate to measure intensity.

It integrates with Pfizer’s existing HemMobile® app, which allows users to log bleeds and infusions, monitor their factor supply, and set appointment reminders.

The data captured generate personalized reports to provide a user’s health care team with insights that can help guide the discussion between a physician and their patient.

Latest Issue
Get instant
access to our latest e-book
THERMOFISHER SEACertara - Is your drug program on trackMasterControl - Manufacturing demoMasterControl - QMS demoThermo Fisher Scientific - Rapid Mycoplasma TestingThermoFisher Scientific - Save costs on your downstream process todayThermo Fisher Scientific - PeptonesMerck - Mobius® products5th Annual Pharma Manufacturing and Automation Convention 2023DUPHAT 202410TH ANNUAL GCC PHARMACY CONGRESS 202314th Annual Emirates Cardiac Society Conference 2023The International Hand & Wrist Congress 2023LabAsia 2023Pharma & Patient USA 2023Pharma Customer Engagement Europe 2023CHEMICAL INDONESIA 2024INALAB 2024